Paper Details

  1. Home
  2. Paper Details

[Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].

Author: AndoM, HashimotoI, MizunoA, MorimotoK, NakamuraT, SakaiK, ShinagawaN, UedaT, WatanabeS, YuraJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Cefpodoxime proxetil (CPDX-PR) was as effective as cefaclor (CCL) in treating skin and soft tissue infections in 243 patients. Both drugs were well tolerated, with no significant differences in side effects or usefulness.
Paper Details　
Original Abstract of the Article :
In order to objectively evaluate the effectiveness, safety and usefulness of the new oral cephem cefpodoxime proxetil (CS-807, CPDX-PR) for the treatment of skin and soft tissue infections, a double-blind comparative study was undertaken using cefaclor (CCL) as the control drug. CPDX-PR and CCL were...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3060626

データ提供：米国国立医学図書館（NLM）

Cefpodoxime Proxetil: A New Oasis in the Treatment of Skin Infections

The world of skin infections can be a challenging landscape, with bacteria and fungi lurking around every corner. This research explores a new oral antibiotic, cefpodoxime proxetil, as a potential oasis in the treatment of skin and soft tissue infections. The study compares the effectiveness of cefpodoxime proxetil to cefaclor, a commonly used antibiotic, in a double-blind clinical trial. Researchers aimed to evaluate the efficacy, safety, and overall usefulness of cefpodoxime proxetil for treating skin infections. Their findings provide valuable insights into the potential benefits and safety of this new antibiotic.

Cefpodoxime Proxetil: A Promising Oasis

The study reveals that cefpodoxime proxetil is comparable to cefaclor in its effectiveness at treating skin and soft tissue infections. This finding offers a glimmer of hope for patients seeking a safe and effective treatment for these common infections. The study also suggests that cefpodoxime proxetil has a favorable safety profile, with few reported side effects. This makes cefpodoxime proxetil a promising addition to the arsenal of antibiotics used to combat skin infections.

Maintaining Healthy Skin: A Journey Through Prevention and Treatment

While cefpodoxime proxetil offers a valuable tool for treating skin infections, it's important to remember that prevention is key. Maintaining good hygiene, practicing safe skin care, and addressing underlying health conditions can help prevent skin infections. If you do develop a skin infection, it's essential to seek prompt medical attention to ensure effective treatment and prevent complications.

Dr.Camel's Conclusion

The study reveals that cefpodoxime proxetil is a promising oasis in the treatment of skin infections. This new antibiotic offers a safe and effective option for patients struggling with these common ailments. But remember, like a wise traveler in the desert, it's important to prioritize prevention and seek prompt medical attention if an infection occurs. By taking these precautions, we can ensure the health and well-being of our skin.

Date :
  1. Date Completed 1989-02-01
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

3060626

DOI: Digital Object Identifier

3060626

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.